Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced its intention to file a registration statement for an initial public offering (IPO) of American Depository Shares in the United States, with the timing and details yet to be confirmed. The offering is contingent on market conditions and the completion of the U.S. SEC review process. Investors are advised that this announcement does not constitute an offer of securities and is subject to change.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.